Peptide aptamers for small molecule drug discovery

Methods in Molecular Biology

Volumn 535, Issue , 2009, Pages 373-388

  Bardou, Carine ^a   Borie, Christophe ^b   Bickle, Marc ^a   Rudkin, Brian B ^b   Colas, Pierre ^a  

^a Aptanomics SA   (France)

^b Univ Claude Bernard   (France)

Author keywords

drug discovery; high throughput screening; luminescence; Peptide aptamers; yeast two hybrid

Indexed keywords

PEPTIDE APTAMER;

ARTICLE; DRUG DEVELOPMENT; GENETICS; HUMAN; LUMINESCENCE; METABOLISM; MOLECULAR LIBRARY; PROTEIN ANALYSIS; PROTEIN BINDING; TWO HYBRID SYSTEM;

APTAMERS, PEPTIDE; DRUG DISCOVERY; HUMANS; LUMINESCENCE; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; SMALL MOLECULE LIBRARIES; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 77649320940     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-557-2_21     Document Type: Article

References (12)

1. Colas, P., Cohen, B., Jessen, T., Grishina, I., McCoy, J. and Brent, R. (1996) Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature 380, 548-550. (Pubitemid 26110646)
2. Hoppe-Seyler, F., Crnkovic-Mertens, I., Tomai, E. and Butz, K. (2004) Peptide apta-mers: specific inhibitors of protein function. Curr. Mol. Med. 4, 529-538. (Pubitemid 38961196)
3. Baines, I.C. and Colas, P. (2006) Peptide aptamers as guides for small molecule drug discovery. Drug Disc. Today 11, 334-341.
4. Colas, P. (2006) Peptide aptamers. In Encyclopedic Reference of Genomics and Proteomics in Molecular Medicine (Ganten, D. and Ruckpaul, K., eds.), Springer, Berlin Hedeil-berg, pp. 1368-1372.
5. Abed, N., Bickle, M., Mari, B., Schapira, M., Sanjuan-Espana, R., Robbe Sermesant, K., et al. (2007) A comparative analysis of perturbations caused by a gene knockout, a dominant negative allele, and a set of pep-tide aptamers. Mol. Cell. Prot. 6, 2110-2121.
6. Xu, X., Leo, C., Jang, Y., Chan, E., Padilla, D., Huang, B.C., et al. (2001) Dominant effector genetics in mammalian cells. Nat. Genet. 27, 23-29. (Pubitemid 32044514)
7. de Chassey, B., Mikaelian, I., Mathieu, A-L., Bickle, M., Olivier, D., Nègre, D., et al. (2007) An antiproliferative genetic screening identifies a peptide aptamer that targets Cal-cineurin and upregulates its activity. Mol. Cell. Prot. 6, 451-459. (Pubitemid 46554540)
8. Borghouts, C., Kunz, C. and Groner, B. (2005) Peptide aptamers: recent developments for cancer therapy. Expert Opin. Biol. Ther. 5, 783-797. (Pubitemid 40873887)
9. Bickle, M., Dusserre, E., Moncorgé, O., Bot-tin, H. and Colas, P. (2006) Selection and characterization of large collections of peptide aptamers through optimized yeast two-hybrid procedures. Nat. Protoc. 1, 1066-1091.
10. Pamonsinlapatham, P., Hadj-Slimane, R., Raynaud, F., Bickle, M., Corneloup, C., Barthelaix, A., et al. (2008) A RasGAP SH3 peptide aptamer inhibits RasGAP-Aurora interaction and induces caspase-independent tumor cell death, PLoS ONE 3, e2902.
11. Nieuwenhuijsen, B.W., Huang, Y., Wang, Y., Ramirez, F., Kalgaonkar, G. and Young, K.H. (2003) A dual luciferase multiplexed high-throughput screening platform for protein-protein interactions. J. Biomol. Screen 8, 676-684.
12. Mukhopadhyay, K., Kohli, A. and Prasad, R. (2002) Drug susceptibilities of yeast cells are affected by membrane lipid composition. Antimicrob. Agents Chemother. 46, 3695-3705. (Pubitemid 35403239)